New endoscopic test for liver vein pressure
Part of Digestive system clinical trials.
This trial tests a new way to measure blood pressure in the main vein of the liver (portal vein) using an endoscope. It may help doctors better understand and manage liver problems without needing a more invasive procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old
- You must have a diagnosis of liver cirrhosis
- You cannot have ascites, kidney problems, or an active infection
- You need to be well enough to agree to both standard and new pressure measurements
- You must not be pregnant or have a serious illness like cancer or a weak immune system
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to measure if a type of blood pressure medicine called non-selective beta-blockers (NSBBs) is helping patients with cirrhosis. It uses a thin, flexible tube with a camera (endoscope) to measure pressures in the liver and a nearby vein. If you have cirrhosis with high pressure in the portal vein but haven't started NSBBs yet, this study may help your doctor decide if the medicine is working for you.
This study uses a special ultrasound with a contrast agent to see if it can diagnose PSVD (a rare liver vessel disorder) without a biopsy. It compares people with PSVD to those with cirrhosis to find better, noninvasive ways to detect this condition.
This trial compares a newer, less invasive method (using an endoscope) to measure pressure in the liver's blood vessels with the standard technique. It may help people with liver disease or suspected cirrhosis better understand their condition.
This study compares a newer, less invasive method using an endoscope (EUS-PPG) with a standard catheter method (HVPG) to measure liver pressure in people with advanced liver disease. The goal is to see if the newer method is equally accurate and safer.
This trial uses a minimally invasive ultrasound technique to directly measure blood pressure in the liver's main vein. It may help doctors decide if patients with severe scarred livers need medication to prevent variceal bleeding.
This early-phase study tests a technique to measure blood pressure changes in people with cirrhosis (scarring of the liver). It may help doctors better understand liver circulation problems and guide safer treatment decisions.
Hear when a new Portal Vein Thrombosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.